DE60019599D1 - 1,2,3,4,5,6,-hexahydroazepino[4,5-b]indole, die arylsulfone an die 9-stellung enthalten - Google Patents

1,2,3,4,5,6,-hexahydroazepino[4,5-b]indole, die arylsulfone an die 9-stellung enthalten

Info

Publication number
DE60019599D1
DE60019599D1 DE60019599T DE60019599T DE60019599D1 DE 60019599 D1 DE60019599 D1 DE 60019599D1 DE 60019599 T DE60019599 T DE 60019599T DE 60019599 T DE60019599 T DE 60019599T DE 60019599 D1 DE60019599 D1 DE 60019599D1
Authority
DE
Germany
Prior art keywords
hydroxypropino
arylsulfones
hexa
indoles containing
indoles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60019599T
Other languages
English (en)
Other versions
DE60019599T2 (de
Inventor
Jon Jacobsen
K Hendges
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Application granted granted Critical
Publication of DE60019599D1 publication Critical patent/DE60019599D1/de
Publication of DE60019599T2 publication Critical patent/DE60019599T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
    • C07C317/36—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atoms of the amino groups bound to hydrogen atoms or to carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/01—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and halogen atoms, or nitro or nitroso groups bound to the same carbon skeleton
    • C07C323/09—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and halogen atoms, or nitro or nitroso groups bound to the same carbon skeleton having sulfur atoms of thio groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60019599T 1999-07-19 2000-07-11 1,2,3,4,5,6,-hexahydroazepino[4,5-b]indole, die arylsulfone an die 9-stellung enthalten Expired - Fee Related DE60019599T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14457499P 1999-07-19 1999-07-19
US144574P 1999-07-19
PCT/US2000/016322 WO2001005793A1 (en) 1999-07-19 2000-07-11 1,2,3,4,5,6-HEXAHYDROAZEPINO[4,5-b]INDOLES CONTAINING ARYLSULFONES AT THE 9-POSITION

Publications (2)

Publication Number Publication Date
DE60019599D1 true DE60019599D1 (de) 2005-05-25
DE60019599T2 DE60019599T2 (de) 2006-03-02

Family

ID=22509195

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60019599T Expired - Fee Related DE60019599T2 (de) 1999-07-19 2000-07-11 1,2,3,4,5,6,-hexahydroazepino[4,5-b]indole, die arylsulfone an die 9-stellung enthalten

Country Status (15)

Country Link
US (4) US6468999B1 (de)
EP (1) EP1196417B8 (de)
JP (1) JP2003505391A (de)
AR (1) AR024773A1 (de)
AT (1) ATE293626T1 (de)
AU (1) AU774794C (de)
CA (1) CA2377718A1 (de)
CO (1) CO5190715A1 (de)
DE (1) DE60019599T2 (de)
ES (1) ES2241624T3 (de)
MY (1) MY122278A (de)
NZ (1) NZ516677A (de)
PE (1) PE20010405A1 (de)
WO (1) WO2001005793A1 (de)
ZA (1) ZA200110536B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7016870B1 (en) 1997-12-02 2006-03-21 Financial Engines Identifying a recommended portfolio of financial products for an investor based upon financial products that are available to the investor
US6292787B1 (en) 1998-09-11 2001-09-18 Financial Engines, Inc. Enhancing utility and diversifying model risk in a portfolio optimization framework
AU2001238660B2 (en) 2000-02-23 2007-05-31 Financial Engines, Inc. Load aware optimization
AU2001292898A1 (en) 2000-09-20 2002-04-02 Brad A. Acker Substituted azepino[4,5b)indole derivatives
US20020160999A1 (en) * 2001-01-08 2002-10-31 Jacobsen Susan Fox Substituted indolines
EP1411925A1 (de) * 2001-08-03 2004-04-28 PHARMACIA & UPJOHN COMPANY 5-arylsulfonyl-indole mit 5-ht6 rezeptor-affinität
US8200561B1 (en) 2002-03-29 2012-06-12 Financial Engines, Inc. Tax-aware asset allocation
TWI329111B (en) 2002-05-24 2010-08-21 X Ceptor Therapeutics Inc Azepinoindole and pyridoindole derivatives as pharmaceutical agents
US7595311B2 (en) * 2002-05-24 2009-09-29 Exelixis, Inc. Azepinoindole derivatives as pharmaceutical agents
US20040248880A1 (en) * 2003-04-25 2004-12-09 Jacobsen Eric Jon 1,2,3,4,5,6-Hexahydroazepino[4,5-B]indoles containing arylsulfones at the 9-position
JP4679517B2 (ja) * 2003-07-23 2011-04-27 エグゼリクシス， インコーポレイテッド 薬剤としてのアゼピン誘導体
JP5420908B2 (ja) * 2005-12-15 2014-02-19 エグゼリクシス， インコーポレイテッド 医薬的薬剤としてのアゼピノインドール誘導体
US8716308B2 (en) 2008-01-11 2014-05-06 Albany Molecular Research, Inc. (1-azinone)-substituted pyridoindoles
WO2010051503A1 (en) 2008-10-31 2010-05-06 Medivation Technologies, Inc. Azepino [4, 5-b] indoles and methods of use
WO2011003012A1 (en) 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof
US8629158B2 (en) 2009-07-01 2014-01-14 Albany Molecular Research, Inc. Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
US8637501B2 (en) 2009-07-01 2014-01-28 Albany Molecular Research, Inc. Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine MCH-1 antagonists, methods of making, and use thereof
US9073925B2 (en) 2009-07-01 2015-07-07 Albany Molecular Research, Inc. Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
WO2012088038A2 (en) 2010-12-21 2012-06-28 Albany Molecular Research, Inc. Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
US8993765B2 (en) 2010-12-21 2015-03-31 Albany Molecular Research, Inc. Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof
WO2018064465A1 (en) 2016-09-29 2018-04-05 The Regents Of The University Of California Compounds for increasing neural plasticity
CN113784962B (zh) 2019-02-27 2025-04-25 加利福尼亚大学董事会 用于治疗脑部疾病的氮杂环庚三烯并-吲哚类和其他杂环
US20230257385A1 (en) 2021-11-17 2023-08-17 Terran Biosciences Inc. Salt and solid forms of tabernanthalog
TW202333668A (zh) 2021-12-15 2023-09-01 美商德利克斯醫療公司 經苯氧基及苄氧基取代之精神成形素(psychoplastogen)及其用途

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1489916A (fr) 1965-07-20 1967-07-28 Bayer Ag Procédé de préparation d'aminophényl-thioéthers
CH462847A (de) 1965-11-11 1968-09-30 Agripat Sa Verfahren zur Herstellung von halogenierten Nitranilinen
GR35044B (el) 1966-05-10 1968-07-31 The Upjohn Company Μεθοδος παρασκευης οργανικων ενωσεων.
US3839357A (en) * 1966-05-10 1974-10-01 Upjohn Co 1,2,3,4,5,6-hexahydroazepino(4,5-b)indoles
US3576872A (en) * 1968-05-03 1971-04-27 Exxon Research Engineering Co Herbicidal s-aryl arylamides
GB1293540A (en) 1968-12-31 1972-10-18 Coalite Chem Prod Ltd Preparation of diaryl ethers and thioethers
NL7008628A (de) 1969-06-25 1970-12-29
US3652588A (en) 1969-10-23 1972-03-28 Upjohn Co 6-alkyl-1 2 3 4 5 6-hexahydroazepino(4 5-b)indoles
US3676558A (en) 1970-08-28 1972-07-11 Upjohn Co Anorexigenic compositions comprising 6-alkyl-1,2,3,4,5,6-hexahydroazepino 4,5-indoles as active ingredient and process of treatment
DE2149645A1 (de) 1970-10-07 1972-09-14 Pfizer 2-Phenyl-as-triazin-3.5-(2H,4H)-dione und die Verwendung dieser Verbindungen zur Bekaempfung der Coccidiose
FR2135740A5 (en) 1971-04-26 1972-12-22 Exxon Research Engineering Co Herbicidal s-aryl arylamides
DE2120708A1 (en) 1971-04-27 1972-11-09 Esso Research and Engineering Co., Linden, NJ. (V.St.A.) Herbicidal s-aryl arylamides
SU380644A1 (ru) 1971-05-18 1973-05-15 Институт естественных наук Бур тского филиала Сибирского отделени СССР Способ получения 3,4,4'-триаминодифенилсульфона
CS149525B1 (de) 1971-07-22 1973-07-25
US3914418A (en) 1971-09-02 1975-10-21 Merck & Co Inc Methods of controlling liver fluke infections
BE789138A (fr) 1971-09-24 1973-03-22 Bayer Ag Nouveaux derives triazeniques, leur procede de preparation et medicament les contenant
SU436817A1 (ru) 1972-04-03 1974-07-25 Всесоюзный Научно-Исследовательский И Проектный Институт Мономеров Способ получени 2,4-динитро-5-амино-1-х-производных бензола
SU475382A1 (ru) 1972-12-19 1975-06-30 Предприятие П/Я В-2304 Огнестойка полимерна композици
DE2313721A1 (de) 1973-03-20 1974-10-03 Bayer Ag Neue 1-phenylsubstituierte 1,3,5triazine, verfahren zu ihrer herstellung, sowie ihre verwendung als arzneimittel
US3948987A (en) * 1974-04-19 1976-04-06 Minnesota Mining And Manufacturing Company Substituted methanesulfonanilides
DE2438099A1 (de) 1974-08-08 1976-02-19 Bayer Ag Substituierte benzothiadiazinyl-carbamidsaeureester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2438120A1 (de) 1974-08-08 1976-02-19 Bayer Ag Substituierte benzimidazolylcarbamidsaeureester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4239888A (en) * 1974-11-04 1980-12-16 Pfizer Inc. 1-Phenyluracils
DE2509037A1 (de) * 1975-03-01 1976-09-02 Bayer Ag 1-aryluracile, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
ZA763751B (en) 1975-06-23 1978-02-22 Syntex Inc 7(8)-substituted triazinobenzimidazoles having antifungal and anthelmintic activity
US4026830A (en) 1975-08-18 1977-05-31 The United States Of America As Represented By The Secretary Of The Navy Poly[tantalum phosphinates]
DE2548910A1 (de) 1975-10-31 1977-05-12 Bayer Ag Neue acylaminonitrobenzol-derivate und verfahren zu ihrer herstellung
CH619460A5 (en) 1976-01-14 1980-09-30 Ciba Geigy Ag Process for the preparation of quinoxaline di-N-oxide derivatives
GB1561230A (en) 1976-02-23 1980-02-13 Sankio Chemical Co Ltd Aminothiofluoran compounds process for the production thereof and recording elements containing the same
DE2748978A1 (de) 1977-11-02 1979-05-03 Basf Ag Azofarbstoffe
GR73690B (de) 1979-01-15 1984-04-02 Celamerck Gmbh & Co Kg
DE2916135A1 (de) 1979-04-20 1980-10-30 Bayer Ag Neue, schwefelhaltige diisocyanate, ein verfahren zu ihrer herstellung, sowie ihre verwendung als aufbaukomponente bei der herstellung von polyurethanen
US4298676A (en) 1979-10-29 1981-11-03 Polaroid Corporation Optical filter agents and photographic products and processes containing same
DE3070467D1 (en) * 1979-11-02 1985-05-15 Sandoz Ag Azepinoindoles, process for their production and pharmaceutical compositions containing them
US4332820A (en) * 1980-01-25 1982-06-01 The Dow Chemical Company Substituted benzonitriles having antiviral activity
DE3008985A1 (de) 1980-03-08 1981-10-01 Basf Ag, 6700 Ludwigshafen N-aryl(thiol)carbamate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
DE3027530A1 (de) 1980-07-19 1982-02-25 Dr. Karl Thomae Gmbh, 7950 Biberach Neue lactame, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3367327D1 (en) 1982-08-06 1986-12-11 American Cyanamid Co Method of modulating the immune response system in mammals
CS229033B1 (cs) 1982-09-28 1984-05-14 Horyna Jaroslav Způsob parciální redukce dinitrodifenylsulfidů, -sulfoxidů a -sulfonů
JPS6044557A (ja) 1983-08-22 1985-03-09 Nippon Kayaku Co Ltd 不溶性モノアゾ化合物及びそれを用いる染色法
US4904794A (en) 1987-03-05 1990-02-27 Ciba-Geigy Corporation Pyrazoline compounds
EP0354303A1 (de) 1988-05-19 1990-02-14 American Cyanamid Company Amidine von Diphenylsulfonen, deren Derivate und deren Verwendung
JPH0248564A (ja) 1988-08-10 1990-02-19 Sumitomo Seika Chem Co Ltd 核置換チオフェノール誘導体の製造方法
US4894358A (en) * 1988-08-31 1990-01-16 Polaroid Corporation Thermal imaging with ylide dyes
DE3831445C2 (de) 1988-09-13 1998-09-10 Joachim K Prof Dr Seydel Verwendung von substituierten 2,4-Diamino-5-benzylpyrimidinen gegebenenfalls in Kombination mit 4,4'-Diaminodiphenylsulfonen zur Behandlung von Malaria
GB8914660D0 (en) 1989-06-26 1989-08-16 Fujisawa Pharmaceutical Co Aniline derivatives,processes for production thereof and pharmaceutical compositions comprising the same
GB9214120D0 (en) 1991-07-25 1992-08-12 Ici Plc Therapeutic amides
WO1994008956A1 (fr) 1992-10-21 1994-04-28 Taisho Pharmaceutical Co., Ltd. ANALOGUE DE N-t-BUTYLANILINE ET REDUCTEUR DU TAUX LIPIDIQUE LE RENFERMANT
IL108630A0 (en) 1993-02-18 1994-05-30 Fmc Corp Insecticidal substituted 2,4-diaminoquinazolines
AU7340696A (en) 1995-10-09 1997-04-30 Chong Kun Dang Corporation Sulfoxide derivatives of nitrogen-mustard and anticancer agent containing the same
KR0183826B1 (ko) 1996-03-04 1999-05-01 김광호 연마공정 후처리용 세정 용액 및 그를 이용하는 세정 방법
US5952349A (en) 1996-07-10 1999-09-14 Schering Corporation Muscarinic antagonists for treating memory loss
DE19654445A1 (de) 1996-12-31 1998-07-02 Seydel Joachim K Prof Dr Verwendung von substituierten 4-Aminodiphenylsulfonen zur Behandlung von entzündlichen Erkrankungen
JP3887769B2 (ja) 1997-12-22 2007-02-28 バイエル コーポレイション 対称および非対称ジフェニル尿素を用いるｐ３８キナーゼの阻害
SI0930302T1 (en) 1998-01-16 2003-10-31 F. Hoffmann-La Roche Ag Benzosulfone derivatives
GB9804648D0 (en) * 1998-03-06 1998-04-29 Zeneca Ltd Chemical compounds
GB9811427D0 (en) * 1998-05-29 1998-07-22 Zeneca Ltd Chemical compounds
DE19829357A1 (de) 1998-07-01 2000-01-05 Bayer Ag Verfahren zur Herstellung von 2-Nitro-5-(phenylthio)-anilinen

Also Published As

Publication number Publication date
US6878823B2 (en) 2005-04-12
ZA200110536B (en) 2003-03-24
NZ516677A (en) 2003-11-28
MY122278A (en) 2006-04-29
EP1196417A1 (de) 2002-04-17
JP2003505391A (ja) 2003-02-12
DE60019599T2 (de) 2006-03-02
US20020111483A1 (en) 2002-08-15
CO5190715A1 (es) 2002-08-29
US20020156275A1 (en) 2002-10-24
CA2377718A1 (en) 2001-01-25
AU774794C (en) 2005-04-14
WO2001005793A1 (en) 2001-01-25
US6468999B1 (en) 2002-10-22
EP1196417B1 (de) 2005-04-20
AR024773A1 (es) 2002-10-23
AU774794B2 (en) 2004-07-08
AU6049700A (en) 2001-02-05
ES2241624T3 (es) 2005-11-01
US6921823B2 (en) 2005-07-26
PE20010405A1 (es) 2001-03-28
EP1196417B8 (de) 2005-06-15
US20020128475A1 (en) 2002-09-12
ATE293626T1 (de) 2005-05-15

Similar Documents

Publication Publication Date Title
DE60019599D1 (de) 1,2,3,4,5,6,-hexahydroazepino[4,5-b]indole, die arylsulfone an die 9-stellung enthalten
IS6320A (is) Pýrazóló [4,3-d] pýrimidín afleiður
DE69928945D1 (de) 4,4-biarylpiperidinederivate mit opioid-receptor-wirkung
AU2001259707A1 (en) 6,5-fused bicyclic heterocycles
TR199800085A3 (tr) 8-Sübstitüye edilmis-1,3,8-triaza- spiro(4,5)dekan-4-on türevleri.
DK0921125T3 (da) 1,3,8-triazaspiro[4.5]decan-4-on-derivater
ID28539A (id) Imidazo (1,2a) azina bersubstitusi sebagai penghambat selektif cox-2
DE50001191D1 (de) Pyrazolo[4, 3-d]pyrimidine
NO971512D0 (no) Nye pyrimido(1,2-a)indoler
DE69900220D1 (de) Diaza-spiro[3,5]nonan-Derivate
EE200000447A (et) 1,3,4-oksadiasolooni derivaadid
FI971310L (fi) 2,7-substituoituja oktahydro-1H-pyrido/1,2-a/pyratsiinijohdannaisia
DE69905798D1 (de) Di- oder Triazaspiro[4,5]decanderivate
NO20011402D0 (no) Tricykliske <delta>3-piperidiner som farmasøytiske midler
NO20011309L (no) Benzotieno [3,2-c]pyridiner som<alfa>2-antagonister
ZA200201873B (en) Fluorene derivatives.
GB0214544D0 (en) 6-Crbamoylpyrimido[4,5-b]Indole derivatives
DK1330457T3 (da) Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoler som 5HT2C-antagonister
ITBO990098U1 (it) Apparecchio per l'illuminazione di emergenza .
DK1175397T3 (da) 3,3-substituerede indolinderivater
GB9918328D0 (en) The billee lamp
ITCT990025A0 (it) La cattedra multimediale attrezzata.
GB9821011D0 (en) The swing line master
IT1311265B1 (it) Dispositivo di illuminazione polifunzionale.
TJ12Y3 (en) The means "Hepatola", having hepatoprotector, antioxidant, antiinflammatory, spazmolitical, hypocholesterinemical, antiathergenuos activity

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee